NFE2L2 and Alzheimer disease: In an in vivo model of Aβ1–42-induced AD, Rhy was able to attenuate the disease symptoms and the in vitro investigations in SH-SY5Y cells revealed that this compound activates Nrf2 nuclear translocation, triggering the expression of its downstream antioxidant enzymes.